150 related articles for article (PubMed ID: 18215971)
1. Advances in radiological staging of non-small cell lung cancer (NSCLC).
Rankin SC
Cancer Imaging; 2004 Feb; 4 Spec No A(Spec No A):S22-4. PubMed ID: 18215971
[TBL] [Abstract][Full Text] [Related]
2. Staging of non-small cell lung cancer (NSCLC).
Rankin SC
Cancer Imaging; 2006 Jan; 6(1):1-3. PubMed ID: 16478697
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
Fischerová D; Cibula D
Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057
[TBL] [Abstract][Full Text] [Related]
5. Use of Magnetic Resonance Imaging for N-Staging in Patients with Non-Small Cell Lung Cancer. A Systematic Review.
Brea TP; Raviña AR; Villamor JMC; Gómez AG; de Alegría AM; Valdés L
Arch Bronconeumol (Engl Ed); 2019 Jan; 55(1):9-16. PubMed ID: 29803524
[TBL] [Abstract][Full Text] [Related]
6. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI.
Schaarschmidt BM; Buchbender C; Nensa F; Grueneisen J; Gomez B; Köhler J; Reis H; Ruhlmann V; Umutlu L; Heusch P
PLoS One; 2015; 10(1):e0116277. PubMed ID: 25574968
[TBL] [Abstract][Full Text] [Related]
7. [CT and MR imaging in the evaluation and staging of lung cancer].
Kuriyama K; Kadota T; Kuroda C
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2140-7. PubMed ID: 2173493
[TBL] [Abstract][Full Text] [Related]
8. CT, positron emission tomography, and MRI in staging lung cancer.
Erasmus JJ; Sabloff BS
Clin Chest Med; 2008 Mar; 29(1):39-57, v. PubMed ID: 18267183
[TBL] [Abstract][Full Text] [Related]
9. Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study.
Schoenmaekers J; Hofman P; Bootsma G; Westenend M; de Booij M; Schreurs W; Houben R; De Ruysscher D; Dingemans AM; Hendriks LEL
Eur J Cancer; 2019 Jul; 115():88-96. PubMed ID: 31129385
[TBL] [Abstract][Full Text] [Related]
10. Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).
Guhlmann A; Storck M; Kotzerke J; Moog F; Sunder-Plassmann L; Reske SN
Thorax; 1997 May; 52(5):438-41. PubMed ID: 9176535
[TBL] [Abstract][Full Text] [Related]
11. The impact of
Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
[TBL] [Abstract][Full Text] [Related]
12. Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?
Hendriks LE; Bootsma GP; de Ruysscher DK; Scheppers NA; Hofman PA; Brans BT; Dingemans AM
Lung Cancer; 2013 Jun; 80(3):293-7. PubMed ID: 23518381
[TBL] [Abstract][Full Text] [Related]
13. Combined contrast-enhanced computed tomography and 18-fluoro-2-deoxy-D-glucose-positron emission tomography in the diagnosis and staging of non-small cell lung cancer.
Allen TL; Kendi AT; Mitiek MO; Maddaus MA
Semin Thorac Cardiovasc Surg; 2011; 23(1):43-50. PubMed ID: 21807298
[TBL] [Abstract][Full Text] [Related]
14. Imaging in cervical cancer.
Follen M; Levenback CF; Iyer RB; Grigsby PW; Boss EA; Delpassand ES; Fornage BD; Fishman EK
Cancer; 2003 Nov; 98(9 Suppl):2028-38. PubMed ID: 14603539
[TBL] [Abstract][Full Text] [Related]
15. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
16. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
[TBL] [Abstract][Full Text] [Related]
17. Systematic Endobronchial Ultrasound-guided Mediastinal Staging Versus Positron Emission Tomography for Comprehensive Mediastinal Staging in NSCLC Before Radical Radiotherapy of Non-small Cell Lung Cancer: A Pilot Study.
Steinfort DP; Siva S; Leong TL; Rose M; Herath D; Antippa P; Ball DL; Irving LB
Medicine (Baltimore); 2016 Feb; 95(8):e2488. PubMed ID: 26937894
[TBL] [Abstract][Full Text] [Related]
18. Imaging of non-small cell lung cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response.
Bruzzi JF; Komaki R; Walsh GL; Truong MT; Gladish GW; Munden RF; Erasmus JJ
Radiographics; 2008; 28(2):561-72. PubMed ID: 18349458
[TBL] [Abstract][Full Text] [Related]
19. The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer.
Eschmann SM; Bitzer M; Paulsen F; Friedel G; Besenfelder H; Horger M; Reimold M; Dittmann H; Pfannenberg AC; Bares R
Nucl Med Commun; 2004 Sep; 25(9):909-15. PubMed ID: 15319596
[TBL] [Abstract][Full Text] [Related]
20. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.
Schmidt GP; Baur-Melnyk A; Herzog P; Schmid R; Tiling R; Schmidt M; Reiser MF; Schoenberg SO
Invest Radiol; 2005 Dec; 40(12):743-53. PubMed ID: 16304476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]